Factors | PCS βa (95% CI) | MCS βa (95%CI) | Symptoms βa (95%CI) | Effects βa (95%CI) | Burden βa (95%CI) |
---|---|---|---|---|---|
Comorbidities | Â | Â | Â | Â | Â |
Yes | Ref. | Ref. | Ref. | Ref. | Ref. |
No | 0.84 (-1.83–3.51) | -2.87 (-6.8–1.06) | -0.22(-7.24–6.8) | 3.35(-3.6–10.33) | -6.21(-14.2–1.82) |
Haemodialysis sessions per week | Â | Â | Â | Â | Â |
1–2 | Ref. | Ref. | Ref. | Ref. | Ref. |
3 | -2.17(-3.64– -0.70)* | 0.97(-1.18–3.12) | 2.15(-1.65–5.95) | -2.80(-6.59–0.98) | -2.79(-7.18–1.60) |
Duration of haemodialysis treatment | Â | Â | Â | Â | Â |
<12 months | Ref. | Ref. | Ref. | Ref. | Ref. |
12–36 months | 0.47(-1.17–2.10) | 0.13(-2.29–2.55) | -5.79(-10.08– -1.49)* | -5.65(-9.91– -1.38)* | -9.08(-14.03– -4.13) |
≥ 37 months | -1.19(-3.144–0.76) | -2.53(-5.42–0.37) | -10.48(-15.6– -5.36)* | -11.9(-16.9– -6.8)* | -9.06(-14.97– -3.15) |
Medication adherence | Â | Â | Â | Â | Â |
Adhered | Ref. | Ref. | Ref. | Ref. | Ref. |
Not adhered | -0.99(-2.36–0.38) | -0.91(-2.94–1.11) | -3.56(-7.14-0.03) | -4.6(-8.17– -1.03)* | -1.78(-5.92–2.36) |
BMI | Â | Â | Â | Â | Â |
Under weight | Ref. | Ref. | Ref. | Ref. | Ref. |
Normal weight | 3.34(1.59–5.08)* | 2.15(-0.43–4.73) | 5.82(1.26–10.38) * | 8.04(3.5–12.59)* | 3.06(-2.22–8.34) |
Overweight | 3.51(0.96–6.07)* | 3.45(-0.31–7.2) | 4.64(-2.11–11.39) | 7.78(1.11–14.44)* | 2.43(-5.25–10.11) |
Obese | 0.07(4.39–4.53) | 9.87(3.28–16.47)* | 17.47(5.71–29.24)* | 15.48(3.84–27.11)* | 20.15(6.67–33.62)* |
Social support | Â | Â | Â | Â | Â |
Poor | Ref. | Ref. | Ref. | Ref. | Ref. |
Moderate | 1.84(0.24–3.43)* | -0.67(-3.03–1.69) | 0.62(-3.56–4.81) | -0.58(-4.75–3.58) | 0.15(-4.67–4.97) |
Strong | 1.68(-0.20–3.57) | -3.67(-6.46–1.87) | -3.76(-8.74–1.22) | 2.67(-2.26–7.59) | 4.09(-1.62–9.8) |